Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
July 21, 2021 at 10:43 AM EDT
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
